Brainsway Ltd. ADR (BWAY)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
Here is how Brainsway Ltd. Sponsored ADR (BWAY) and CG Oncology, Inc. (CGON) have performed compared to their sector so far this year.
Recent Price Trend in Brainsway (BWAY) is Your Friend, Here's Why
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
BrainsWay: Competitive Threats Are Mounting
BrainsWay continues to deliver strong growth and margin improvement, supported by investments in TMS service providers and recurring revenue expansion. BWAY's accelerated protocol and expanded indications, including adolescent depression, are supportive of further growth. TMS is a relatively expensive treatment option though with a high patient burden, making the impeding entry of psychedelics (psilocybin, LSD, DMT) into the market a serious threat.
BrainsWay Ltd (BWAY) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 68/100
On April 22, 2026, BrainsWay Ltd (BWAY) shares rose 3.4% today, bringing the current price to $15.85. The stock has seen significant upward movement in the past
Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know
Brainsway (BWAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
Brainsway (BWAY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Why Brainsway (BWAY) Might be Well Poised for a Surge
Brainsway Ltd. Sponsored ADR (BWAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
3 Stocks With Recent Price Strength Despite a Tumultuous March
CDNL, BWAY and CENX are three stocks defying market weakness, with strong price momentum amid geopolitical turmoil.
Here's Why Momentum in Brainsway (BWAY) Should Keep going
If you are looking for stocks that are well positioned to maintain their recent uptrend, Brainsway (BWAY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
BrainsWay: Strong Execution, But Valuation Limits Upside
BrainsWay has delivered strong revenue growth, expanding its leasing model and recurring revenue base. BWAY reported 27% annual revenue growth, 75.4% gross margin, and issued 2026 guidance for $66–68M revenue and $12–14M adjusted EBITDA. The leasing model drives high-margin, stable recurring revenue with 93% customer retention and $70M in remaining performance obligations.
Brainsway (NASDAQ:BWAY) Reaches New 12-Month High on Better-Than-Expected Earnings
Brainsway Ltd. Sponsored ADR (NASDAQ: BWAY - Get Free Report) shares hit a new 52-week high during trading on Wednesday following a stronger than expected earnings report. The company traded as high as $13.75 and last traded at $13.29, with a volume of 102207 shares. The stock had previously closed at $12.71. The company reported $0.14
BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens
BrainsWay stock rises after Optum expands Deep TMS coverage for adolescents, boosting reimbursement visibility.
